Global Glucan Market Strategic Research Report
By Type: Yeast Derived Glucan, Cereal Derived Glucan, Mushroom Derived Glucan, Algae Derived Glucan, Others
By Application: Functional Food and Beverage, Dietary Supplement, Pharmaceutical, Animal Feed, Personal Care and Cosmetic, Others
Regional Forecast: Asia Pacific, Latin America, MEA, Europe, North America
Key Players: Ohly (DE), Nutragreenbio (CN), Kemin (US), Super Beta Glucan (US), Tate & Lyle (UK), Lesaffre International (FR), Kerry Group (IE), DSM-Firmenich (CH), Lallemand (CA), Biorigin (BR), Garuda International (US), Angel Yeast (CN), Nanjing Tessin Biotechnology (CN), Aureo Co (Japan)
نظرة عامة
Scope of the Report
The global Glucan market size is predicted to grow from US$ 740 million in 2025 to US$ 1,132 million in 2032; it is expected to grow at a CAGR of 6.5% from 2026 to 2032.
Glucan refers to a class of polysaccharides composed of D-glucose monomers linked by glycosidic bonds, including β-1,3, β-1,4, and β-1,6 or α-1,3/1,4/1,6 linkages, widely derived from yeast, fungi, cereals, and algae, and valued for their functional properties such as immune modulation, viscosity control, and bioactivity in food, pharmaceutical, cosmetic, and industrial applications.
The glucan industry chain begins upstream with raw material supply including yeast strains, cereal crops such as oats and barley, mushrooms, and microalgae cultivation supported by fermentation media and agricultural inputs, followed by midstream processing involving fermentation, enzymatic extraction, purification, drying, and formulation into powders or liquids by specialized biochemical manufacturers, and extends downstream to diverse applications where glucan is incorporated into functional foods, nutraceutical supplements, pharmaceutical formulations, cosmetics, animal feed, and agricultural products, ultimately reaching consumers through retail, healthcare, and industrial distribution channels supported by regulatory compliance, branding, and scientific validation activities.
Current and planned glucan-related projects globally focus on expanding fermentation capacity for yeast-derived beta-glucan production in Asia and Europe, scaling microalgae-based paramylon facilities for sustainable bioproduct development, upgrading extraction plants for oat and barley beta-glucan in North America, investing in pharmaceutical-grade glucan purification facilities with GMP compliance, developing integrated biorefineries combining glucan with other bioactive compounds, and establishing new production lines for high-purity and customized glucan formulations targeting functional foods, immune health supplements, and cosmetic applications, supported by increasing demand and government incentives for biotechnology and health-related industries.
2025 Global Market sales Volume: 42,000 tons. Average Global Market Price: USD 18/kg. Market Average Gross Profit Margin: 38%.
The global glucan market has experienced steady growth driven by increasing consumer awareness of immune health, functional nutrition, and natural bioactive ingredients, with beta-glucan in particular gaining strong scientific and commercial recognition across food, pharmaceutical, and personal care sectors. Market development has been supported by advances in biotechnology and fermentation processes, enabling higher purity, better functionality, and scalable production, while regulatory approvals in major markets have further validated glucan’s health benefits and expanded its commercial applications. Regionally, Asia-Pacific leads in production, especially in fermentation-based glucan from countries with strong biotech capabilities, while North America and Europe dominate high-value consumption due to mature nutraceutical and functional food markets and higher consumer purchasing power.
Opportunities in the glucan market are driven by rising demand for immune-boosting ingredients, aging populations, increasing prevalence of chronic diseases, and expanding applications in cosmetics and animal nutrition, while emerging segments such as microalgae-derived glucan and pharmaceutical-grade formulations present high-growth potential. However, risks include raw material price volatility, regulatory complexities across regions, variability in product quality and standardization, and competition from alternative functional ingredients such as probiotics and plant extracts. Market trends indicate a shift toward high-purity, clinically validated glucan products, clean-label and natural formulations, and sustainable production methods, including fermentation and algae-based processes.
From a competitive standpoint, the market is moderately fragmented, with a mix of specialized biotech companies, ingredient suppliers, and large food and pharmaceutical firms, where technological capability, strain development, and purification processes serve as key differentiators, while branding and clinical evidence increasingly influence downstream market success. Leading players are focusing on vertical integration, strategic partnerships, and product innovation to strengthen their positions, while smaller companies compete through niche applications and customized formulations, resulting in a dynamic and innovation-driven competitive landscape.
Key Questions Addressed in this Report
What is the 10-year outlook for the global Glucan market?
What factors are driving Glucan market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Glucan market opportunities vary by end market size?
How does Glucan break out by Type, by Application?
This report presents a comprehensive overview of the global Glucan market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.
Segment by Type
- Yeast Derived Glucan
- Cereal Derived Glucan
- Mushroom Derived Glucan
- Algae Derived Glucan
- Others
Segment by Solubility
- Soluble Glucan
- Insoluble Glucan
Segment by Purity
- <30% Glucan Content
- 30% – 60% Glucan Content
- >60% Glucan Content
Segment by Application
- Functional Food and Beverage
- Dietary Supplement
- Pharmaceutical
- Animal Feed
- Personal Care and Cosmetic
- Others
Who Can Use This Report?
This report is written for decision-makers who need a clear, data-backed view of the global Glucan market:
- Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
- Distributors, channel partners and end users in Functional Food and Beverage, Dietary Supplement, Pharmaceutical evaluating demand and sourcing options
- Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
- Government agencies, industry associations and research institutions tracking industry developments and policy impact
Market snapshot
Global Glucan Market Strategic Research Report snapshot, 2025–2032
© MarketResearchReports.comDisclaimer: The actual data may vary in the final report which undergoes verification check post order confirmation.Segments covered in this report
Table of contents
01Executive Summary
02Industry Overview & Forecast
- 2.1.1 Market Definition and Scope
- 2.1.2 Market Size and Growth Forecast
- 2.1.3 Volume Analysis
- 2.1.4 Segment Outlook by Type
- 2.1.5 Segment Outlook by Application
- 2.1.6 Regional Outlook
- 2.1.7 Structural Developments Shaping the Forecast
- 2.1.8 Forecast Risks and Sensitivities
03Market Segmentation by Type
- 3.1 Market Segmentation by Type
- 3.1.1 Market by Type Overview
- 3.1.2 Yeast Derived Glucan
- 3.1.3 Cereal Derived Glucan
- 3.1.4 Mushroom Derived Glucan
- 3.1.5 Algae Derived Glucan
- 3.1.6 Others
- 3.1.7 Volume Analysis
04Market Segmentation by Application
- 4.1 Market Segmentation by Application
- 4.1.1 Market by Application Overview
- 4.1.2 Functional Food and Beverage
- 4.1.3 Dietary Supplement
- 4.1.4 Pharmaceutical
- 4.1.5 Animal Feed
- 4.1.6 Personal Care and Cosmetic
- 4.1.7 Others
- 4.1.8 Volume Analysis
05Regional Market Forecast
- Asia Pacific
- North America
- Europe
- Middle East & Africa
- Latin America
06Country-Level Market Forecast
- 6.1 Asia Pacific
- 6.1.1 China
- 6.1.2 Japan
- 6.1.3 Korea
- 6.1.4 Southeast Asia
- 6.1.5 India
- 6.1.6 Australia
- 6.1.7 Rest of Asia Pacific
- 6.2 North America
- 6.2.1 United States
- 6.2.2 Canada
- 6.2.3 Mexico
- 6.2.4 Rest of North America
- 6.3 Europe
- 6.3.1 Germany
- 6.3.2 France
- 6.3.3 UK
- 6.3.4 Italy
- 6.3.5 Russia
- 6.3.6 Rest of Europe
- 6.4 Middle East & Africa
- 6.4.1 Egypt
- 6.4.2 South Africa
- 6.4.3 Israel
- 6.4.4 Turkey
- 6.4.5 GCC Countries
- 6.4.6 Rest of Middle East & Africa
- 6.5 Latin America
- 6.5.1 Brazil
- 6.5.2 Rest of Latin America
07Growth Drivers & Inhibitors
- 7.1 Growth Drivers & Inhibitors
- 7.1.1 Section Overview
- 7.1.2 Growth Drivers
- 7.1.3 Growth Inhibitors
- 7.1.4 Driver and Inhibitor Impact Assessment
- 7.1.5 Analyst Perspective
08Key Company Profiles
- 8.1 Ohly (DE)
- 8.1.1 Company Overview
- 8.1.2 Key Products & Segments
- 8.1.3 Financial Performance (2023–2025)
- 8.1.4 Business Strategy
- 8.1.5 SWOT Analysis
- 8.1.6 Strategic Implications (2026–2032)
- 8.2 Nutragreenbio (CN)
- 8.2.1 Company Overview
- 8.2.2 Key Products & Segments
- 8.2.3 Financial Performance (2023–2025)
- 8.2.4 Business Strategy
- 8.2.5 SWOT Analysis
- 8.2.6 Strategic Implications (2026–2032)
- 8.3 Kemin (US)
- 8.3.1 Company Overview
- 8.3.2 Key Products & Segments
- 8.3.3 Financial Performance (2023–2025)
- 8.3.4 Business Strategy
- 8.3.5 SWOT Analysis
- 8.3.6 Strategic Implications (2026–2032)
- 8.4 Super Beta Glucan (US)
- 8.4.1 Company Overview
- 8.4.2 Key Products & Segments
- 8.4.3 Financial Performance (2023–2025)
- 8.4.4 Business Strategy
- 8.4.5 SWOT Analysis
- 8.4.6 Strategic Implications (2026–2032)
- 8.5 Tate & Lyle (UK)
- 8.5.1 Company Overview
- 8.5.2 Key Products & Segments
- 8.5.3 Financial Performance (2023–2025)
- 8.5.4 Business Strategy
- 8.5.5 SWOT Analysis
- 8.5.6 Strategic Implications (2026–2032)
- 8.6 Lesaffre International (FR)
- 8.6.1 Company Overview
- 8.6.2 Key Products & Segments
- 8.6.3 Financial Performance (2023–2025)
- 8.6.4 Business Strategy
- 8.6.5 SWOT Analysis
- 8.6.6 Strategic Implications (2026–2032)
- 8.7 Kerry Group (IE)
- 8.7.1 Company Overview
- 8.7.2 Key Products & Segments
- 8.7.3 Financial Performance (2023–2025)
- 8.7.4 Business Strategy
- 8.7.5 SWOT Analysis
- 8.7.6 Strategic Implications (2026–2032)
- 8.8 DSM-Firmenich (CH)
- 8.8.1 Company Overview
- 8.8.2 Key Products & Segments
- 8.8.3 Financial Performance (2023–2025)
- 8.8.4 Business Strategy
- 8.8.5 SWOT Analysis
- 8.8.6 Strategic Implications (2026–2032)
- 8.9 Lallemand (CA)
- 8.9.1 Company Overview
- 8.9.2 Key Products & Segments
- 8.9.3 Financial Performance (2023–2025)
- 8.9.4 Business Strategy
- 8.9.5 SWOT Analysis
- 8.9.6 Strategic Implications (2026–2032)
- 8.10 Biorigin (BR)
- 8.10.1 Company Overview
- 8.10.2 Key Products & Segments
- 8.10.3 Financial Performance (2023–2025)
- 8.10.4 Business Strategy
- 8.10.5 SWOT Analysis
- 8.10.6 Strategic Implications (2026–2032)
- 8.11 Garuda International (US)
- 8.11.1 Company Overview
- 8.11.2 Key Products & Segments
- 8.11.3 Financial Performance (2023–2025)
- 8.11.4 Business Strategy
- 8.11.5 SWOT Analysis
- 8.11.6 Strategic Implications (2026–2032)
- 8.12 Angel Yeast (CN)
- 8.12.1 Company Overview
- 8.12.2 Key Products & Segments
- 8.12.3 Financial Performance (2023–2025)
- 8.12.4 Business Strategy
- 8.12.5 SWOT Analysis
- 8.12.6 Strategic Implications (2026–2032)
- 8.13 Nanjing Tessin Biotechnology (CN)
- 8.13.1 Company Overview
- 8.13.2 Key Products & Segments
- 8.13.3 Financial Performance (2023–2025)
- 8.13.4 Business Strategy
- 8.13.5 SWOT Analysis
- 8.13.6 Strategic Implications (2026–2032)
- 8.14 Aureo Co (Japan)
- 8.14.1 Company Overview
- 8.14.2 Key Products & Segments
- 8.14.3 Financial Performance (2023–2025)
- 8.14.4 Business Strategy
- 8.14.5 SWOT Analysis
- 8.14.6 Strategic Implications (2026–2032)
09Competitive Landscape
- 9.1 Competitive Landscape Overview
- 9.2 Competitive Intensity Assessment
- 9.3 Key Player Strategies & Positioning
- 9.4 Competitive Dynamics & Strategic Outlook
- 9.4.1 Emerging Competitive Threats
- 9.4.2 Consolidation vs. Fragmentation Outlook
- 9.4.3 Competitive Response Matrix
- 9.4.4 Strategic Recommendations, 2026–2032
10Porter's Five Forces Analysis
- 10.1 Threat of New Entrants
- 10.2 Bargaining Power of Buyers
- 10.3 Bargaining Power of Suppliers
- 10.4 Threat of Substitutes
- 10.5 Competitive Rivalry
11PESTLE Analysis
- 11.1 Political
- 11.2 Economic
- 11.3 Social and Demographic
- 11.4 Technological
- 11.5 Legal and Regulatory
- 11.6 Environmental
- 11.7 Strategic Implications of the PESTLE Assessment
12SWOT Analysis
13Future Trends & Outlook
- 13.1 Future Trends & Outlook
- 13.1.1 Trend Summary and Commercial Maturity Assessment
- 13.1.2 Technology and Innovation Trends
- 13.1.3 Long-Term Market Outlook
- 13.1.4 Investment & M&A Activity Outlook
- 13.1.5 Overall Outlook Assessment
Frequently asked questions
How big is the global Glucan market?
How fast is the Glucan market expected to grow?
What does the Glucan market cover?
What are the main segments of the Glucan market by type?
Which applications drive demand in the Glucan market?
Who are the key players in the Glucan market?
Which regions and countries are covered for Glucan?
What is driving growth in the Glucan market?
What challenges does the Glucan market face?
Who should buy the Glucan market report?
What license options are available for this report?
Research Methodology
All MarketResearchReports.com strategic research reports follow a rigorous, multi-stage methodology combining AI-assisted data synthesis with expert analyst validation.
Systematic collection from 500+ verified sources including SEC filings, industry databases (Bloomberg, Statista, OECD), regulatory filings, trade publications, patent databases, and company annual reports. AI-assisted extraction identifies relevant data points across 10,000+ documents per report.
Dual-validation approach: bottom-up sizing aggregates segment-level production, consumption, and trade data; top-down sizing cross-validates against macroeconomic indicators and total addressable market estimates. Discrepancies >5% trigger analyst review.
Company profiles built from public financial disclosures, product launches, M&A activity, job postings (as capability proxies), and supply chain mapping. Market share estimates triangulated across revenue, capacity, and shipment data.
CAGR projections use time-series regression on 5-10 years of historical data, adjusted for identified demand drivers (technology adoption curves, regulatory catalysts, demographic shifts) and demand inhibitors (cost barriers, substitution risk). Scenario modeling covers base, optimistic, and conservative cases.
All quantitative outputs reviewed by a domain-specialist analyst before publication. Data triangulation requires minimum 3 independent sources for every key figure. Reports undergo a structured peer review against our 47-point quality checklist covering methodology, data citations, logical consistency, and formatting standards.
On-demand reports are generated at time of purchase, incorporating the most recent available data. Static reports are republished when underlying market conditions shift by >10% from baseline assumptions. Purchasers receive update notifications for 12 months.
Need a customized version?
Get country-, segment- or company-specific intelligence tailored to your exact requirements.
Request custom research →Request a free sample
Receive a sample of Global Glucan Market Strategic Research Report before you buy.
Customize This Report
Describe your specific requirements and our analysts will scope and deliver a tailored version.
Request Invoice
We will email a proforma invoice within 24 hours. Report access is granted upon payment confirmation.
Navadhi Market Research · Food & Beverages